XELODA for Rectal cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 48 adverse event reports in the FDA FAERS database where XELODA was used for Rectal cancer.
Most Reported Side Effects for XELODA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 303 | 28.2% | 302 | 13 |
| Diarrhoea | 141 | 13.1% | 31 | 53 |
| Disease progression | 137 | 12.7% | 42 | 13 |
| Nausea | 81 | 7.5% | 19 | 30 |
| Vomiting | 71 | 6.6% | 13 | 41 |
| Palmar-plantar erythrodysaesthesia syndrome | 70 | 6.5% | 5 | 16 |
| Fatigue | 50 | 4.7% | 10 | 12 |
| Malignant neoplasm progression | 45 | 4.2% | 8 | 7 |
| Pain | 37 | 3.4% | 9 | 13 |
| Asthenia | 36 | 3.4% | 9 | 20 |
| Decreased appetite | 32 | 3.0% | 8 | 17 |
| Dehydration | 32 | 3.0% | 10 | 22 |
| Weight decreased | 31 | 2.9% | 3 | 14 |
| Abdominal pain | 29 | 2.7% | 7 | 18 |
| Breast cancer | 29 | 2.7% | 3 | 2 |
Other Indications for XELODA
Product used for unknown indication (215)
Colon cancer (157)
Breast cancer (147)
Breast cancer metastatic (102)
Colorectal cancer (68)
Gastric cancer (56)
Pancreatic carcinoma (25)
Colorectal cancer metastatic (23)
Colon cancer metastatic (22)
Oesophageal carcinoma (18)
Other Drugs Used for Rectal cancer
CAPECITABINE (2,976)
OXALIPLATIN (2,402)
FLUOROURACIL (1,610)
BEVACIZUMAB (1,546)
TIPIRACIL\TRIFLURIDINE (1,297)
IRINOTECAN (985)
LEUCOVORIN (660)
CETUXIMAB (542)
REGORAFENIB (505)
PANITUMUMAB (374)